Cargando…
Exenatide Treatment Causes Suppression of Serum Ghrelin Levels following Mixed Meal Test in Obese Diabetic Women
Aim. To investigate the effect of exenatide treatment on serum ghrelin levels in obese female patients with type 2 diabetes mellitus. Methods. Fourteen female patients with type 2 diabetes mellitus being treated with metformin and exenatide were enrolled. A mixed meal test was applied to the patient...
Autores principales: | Topyildiz, Figen, Kiyici, Sinem, Gul, Zulfiye, Sigirli, Deniz, Guclu, Metin, Kisakol, Gurcan, Cavun, Sinan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4779845/ https://www.ncbi.nlm.nih.gov/pubmed/26998491 http://dx.doi.org/10.1155/2016/1309502 |
Ejemplares similares
-
Exenatide treatment causes suppression of serum fasting ghrelin levels in patients with type 2 diabetes mellitus
por: Guclu, Metin, et al.
Publicado: (2017) -
Serum macroprolactin levels in pregnancy and association with thyroid autoimmunity
por: Guclu, Metin, et al.
Publicado: (2015) -
Hypokalemic paralysis; an unusual presentation of Conn's Syndrome
por: Güller, Pınar Üzgeç, et al.
Publicado: (2023) -
Ghrelin cell–expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin
por: Shankar, Kripa, et al.
Publicado: (2021) -
The vascular function effects of adding exenatide or meal insulin to basal insulin therapy in early type 2 diabetes
por: Retnakaran, Ravi, et al.
Publicado: (2023)